241 related articles for article (PubMed ID: 37270717)
1. ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis.
Zheng X; Du Y; Liu M; Wang C
Funct Integr Genomics; 2023 Jun; 23(2):196. PubMed ID: 37270717
[TBL] [Abstract][Full Text] [Related]
2. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
[TBL] [Abstract][Full Text] [Related]
3. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.
Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R
BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
Wang JR; Liu B; Zhou L; Huang YX
Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
[TBL] [Abstract][Full Text] [Related]
5. Identifying the prognosis implication, immunotherapy response prediction value, and potential targeted compound inhibitors of integrin subunit α3 (ITGA3) in human cancers.
Gui J; Yang L; Liu J; Li Y; Zou M; Sun C; Huang L; Zhu X; Huang K
Heliyon; 2024 Jan; 10(2):e24236. PubMed ID: 38293430
[TBL] [Abstract][Full Text] [Related]
6. Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma.
Feng C; Jin X; Han Y; Guo R; Zou J; Li Y; Wang Y
Med Sci Monit; 2020 Oct; 26():e926800. PubMed ID: 33099569
[TBL] [Abstract][Full Text] [Related]
7. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma.
Huang Y; Kong Y; Zhang L; He T; Zhou X; Yan Y; Zhang L; Zhou D; Lu S; Zhou J; Zhou L; Xie H; Zheng S; Wang W
Biomed Res Int; 2018; 2018():2352139. PubMed ID: 29511671
[TBL] [Abstract][Full Text] [Related]
8. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
9. A human integrin-α3 mutation confers major renal developmental defects.
Shukrun R; Vivante A; Pleniceanu O; Vax E; Anikster Y; Dekel B; Lotan D
PLoS One; 2014; 9(3):e90879. PubMed ID: 24621570
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑199a‑5p suppresses cell proliferation, migration and invasion by targeting ITGA3 in colorectal cancer.
Tian L; Chen M; He Q; Yan Q; Zhai C
Mol Med Rep; 2020 Sep; 22(3):2307-2317. PubMed ID: 32705201
[TBL] [Abstract][Full Text] [Related]
11. miRNA-144-5p/ITGA3 Suppressed the Tumor-Promoting Behaviors of Thyroid Cancer Cells by Downregulating ITGA3.
Zhang J; Zhong Y; Sang Y; Ren G
Comput Math Methods Med; 2021; 2021():9181941. PubMed ID: 34938358
[TBL] [Abstract][Full Text] [Related]
12. Integrin α3 Mediates Stemness and Invasion of Glioblastoma by Regulating POU3F2.
Yao J; Wang L
Curr Protein Pept Sci; 2023; 24(3):247-256. PubMed ID: 36843258
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer.
Hu F; Zhao L; Wang Y; Ye H; Tang H; Zhou J
Open Med (Wars); 2022; 17(1):1935-1943. PubMed ID: 36561844
[TBL] [Abstract][Full Text] [Related]
14. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced changes to integrin α 3 glycosylation facilitate invasion in epidermoid carcinoma cell line A431.
Ren Y; Hao P; Law SK; Sze SK
Mol Cell Proteomics; 2014 Nov; 13(11):3126-37. PubMed ID: 25078904
[TBL] [Abstract][Full Text] [Related]
16. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract][Full Text] [Related]
17. Interference with circBC048201 inhibits the proliferation, migration, and invasion of bladder cancer cells through the miR-1184/ITGA3 axis.
Jiang P; Zhu Y; Xu Z; Chen X; Xie L
Mol Cell Biochem; 2020 Nov; 474(1-2):83-94. PubMed ID: 32789658
[TBL] [Abstract][Full Text] [Related]
18. Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
Chen WL; Wang XK; Wu W
Curr Med Sci; 2018 Aug; 38(4):714-720. PubMed ID: 30128883
[TBL] [Abstract][Full Text] [Related]
19. The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation.
Chernaya G; Mikhno N; Khabalova T; Svyatchenko S; Mostovich L; Shevchenko S; Gulyaeva L
Surg Oncol; 2018 Dec; 27(4):702-708. PubMed ID: 30449496
[TBL] [Abstract][Full Text] [Related]
20. Decreased Expression of Integrin Subunits α3, α6, and α8 in the Branching Airway Mesenchyme of Nitrofen-Induced Hypoplastic Lungs.
Takahashi T; Friedmacher F; Zimmer J; Puri P
Eur J Pediatr Surg; 2018 Feb; 28(1):109-114. PubMed ID: 28701000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
